Compare TREE & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TREE | DNA |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.0M | 607.1M |
| IPO Year | 2008 | N/A |
| Metric | TREE | DNA |
|---|---|---|
| Price | $41.91 | $6.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $70.80 | $10.50 |
| AVG Volume (30 Days) | 568.3K | ★ 1.0M |
| Earning Date | 06-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.81 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $900,219,000.00 | N/A |
| Revenue This Year | $6.24 | $1.60 |
| Revenue Next Year | $3.37 | N/A |
| P/E Ratio | $89.08 | ★ N/A |
| Revenue Growth | ★ 33.86 | N/A |
| 52 Week Low | $32.65 | $5.00 |
| 52 Week High | $77.35 | $17.58 |
| Indicator | TREE | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 34.37 |
| Support Level | $33.37 | N/A |
| Resistance Level | $59.46 | $10.05 |
| Average True Range (ATR) | 3.22 | 0.59 |
| MACD | 1.32 | -0.26 |
| Stochastic Oscillator | 50.83 | 3.52 |
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.